Investigating the Effectiveness of Vimida

NAActive, not recruitingINTERVENTIONAL

Enrollment

160

Participants

Timeline

Start Date

February 13, 2025

Primary Completion Date

September 30, 2025

Study Completion Date

December 31, 2025

Conditions

Long COVIDPost COVID-19 Condition

Interventions

BEHAVIORAL

vimida

Participants will receive access to the digital health intervention vimida in addition to TAU.

Trial Locations (1)

GAIA, Hamburg

All Listed Sponsors

collaborator

Medical School Hamburg

OTHER

collaborator

Institut Long-Covid Rostock

UNKNOWN

lead

Gaia AG

INDUSTRY